Neuropathic Pain Market: Global Industry Analysis and Forecast 2014 - 2020
- Submitted by: veronicasavio
- Views: 215
- Category: Other
- Date Submitted: 03/09/2015 02:24 AM
- Pages: 4
- Report this Essay
Neuropathic Pain Market: Global Industry Analysis and Forecast 2014 - 2020
Persistence Market Research
Neuropathic Pain Market: Global Industry Analysis and Forecast 2014 - 2020
Persistence Market Research
1
Neuropathic Pain Market: Global Industry Analysis and Forecast 2014 - 2020 Persistence Market Research Released New Market Report on “Neuropathic Pain Market: Global Industry Analysis and Forecast 2014 - 2020”.
Neuropathic pain results from damage or dysfunction of the peripheral and central nervous system (CNS). Pain can develop after injury to any level of the nervous system. Some of the major syndromes include postherpetic neuralgia, painful traumatic mononeuropathy, root avulsions, painful polyneuropathy, central pain syndromes, postsurgical pain syndromes, and complex regional pain syndrome. Most commonly prescribed medications for neuropathic pain include antidepressants (also known as tricyclic antidepressants), anticonvulsants (also called neuroleptic medications), and anesthetics. Major antidepressants include Nortriptiline and Amitriptyline. Carbamazepine, Valproic Acid, Felbamate, Clonazepam, and Phenytoin are the most commonly used anticonvulsants for the treatment of neuropathic disorders. Major anesthetics used to reduce neuropathic pain are Tocainide or Mexiletine and Idocaine. Antidepressants and anticonvulsants are the first line of treatment for neuropathic pain. The combination of these two medications is thought to be particularly effective in the treatment of neuropathic pain.
Buy Full Report: http://www.persistencemarketresearch.com/market-research/neuropathic-painmarket.asp
The global neuropathic pain market is categorized based on various forms of neuropathic pain and their therapeutics. Based on types, the report covers postherpetic neuralgia, painful diabetic neuropathy, and trigeminal neuralgia. The drug segment is further sub-segmented into antidepressants, cannabinoids, dietary supplements, neuromodulators, anticonvulsants...
Persistence Market Research
Neuropathic Pain Market: Global Industry Analysis and Forecast 2014 - 2020
Persistence Market Research
1
Neuropathic Pain Market: Global Industry Analysis and Forecast 2014 - 2020 Persistence Market Research Released New Market Report on “Neuropathic Pain Market: Global Industry Analysis and Forecast 2014 - 2020”.
Neuropathic pain results from damage or dysfunction of the peripheral and central nervous system (CNS). Pain can develop after injury to any level of the nervous system. Some of the major syndromes include postherpetic neuralgia, painful traumatic mononeuropathy, root avulsions, painful polyneuropathy, central pain syndromes, postsurgical pain syndromes, and complex regional pain syndrome. Most commonly prescribed medications for neuropathic pain include antidepressants (also known as tricyclic antidepressants), anticonvulsants (also called neuroleptic medications), and anesthetics. Major antidepressants include Nortriptiline and Amitriptyline. Carbamazepine, Valproic Acid, Felbamate, Clonazepam, and Phenytoin are the most commonly used anticonvulsants for the treatment of neuropathic disorders. Major anesthetics used to reduce neuropathic pain are Tocainide or Mexiletine and Idocaine. Antidepressants and anticonvulsants are the first line of treatment for neuropathic pain. The combination of these two medications is thought to be particularly effective in the treatment of neuropathic pain.
Buy Full Report: http://www.persistencemarketresearch.com/market-research/neuropathic-painmarket.asp
The global neuropathic pain market is categorized based on various forms of neuropathic pain and their therapeutics. Based on types, the report covers postherpetic neuralgia, painful diabetic neuropathy, and trigeminal neuralgia. The drug segment is further sub-segmented into antidepressants, cannabinoids, dietary supplements, neuromodulators, anticonvulsants...